Journals / Bakırköy Tıp Dergisi / 2014 / Cilt: 10 - Sayı: 4

Evaluation of incidence and effective risk factors in development of retinopathy of prematurity

Prematüre Retinopatisi Gelişim Sıklığı ve Etki Eden Risk Faktörlerinin

Pages
158–164
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Development of ROP which is the second cause of acquired visual loss in the world has multifactorial etiology and for reducing the incidence low birth weight babies should be examined with taking into account these factors

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The object of the study is to determine the frequency and associated factors in development of ROP at very low birth weight infants born in our hospital and hospitalized in neonatal intensive care unit.
📊
Key Findings & Data:Material and Method: 246 babies born and followed up in our hospital between January 2007 and December 2011 and had birth weight < 1500 g were evaluated retrospectively.
💡
Conclusion & Impact:Conclusion: Development of ROP which is the second cause of acquired visual loss in the world has multifactorial etiology and for reducing the incidence low birth weight babies should be examined with taking into account these factors
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The object of the study is to determine the frequency and associated factors in development of ROP at very low birth weight infants born in our hospital and hospitalized in neonatal intensive care unit. Material and Method: 246 babies born and followed up in our hospital between January 2007 and December 2011 and had birth weight < 1500 g were evaluated retrospectively. Effective factors on development of retinopaty of prematurity were evaluated. Results: Of these patients, 55 (22.4%) were diagnosed with ROP. The mean gestational age in babies diagnosed as ROP was 28.3±2.3 weeks and we found that with decreasing gestational age risk of development of ROP increased (p: 0.011). Of 55 patients with diagnosis of ROP; 29 (%52.7) were followed up with stage 1, 17 (%30.9) were at stage 2, 8 (%14.6) were at stage 3 and 1 patient was (%1.8) at stage 5. We detected statistically significant correlation between development of ROP and PDA, advanced stage of NEC (stage 2-3), sepsis, presence of BPD (p values respectively; p=0.0001, p=0.004, p=0.003, p=0.0001 and p=0.002). There was no relationship with mechanical ventilation, CPAP application and surfactant application. Factors such as maternal hypertension, diabetes, preeclampsia, smoking, age and mode of delivery were not associated with development of ROP. From the 55 cases detected retinopathy of prematurity, 9 (%16.3) had &#8805; stage 3 ROP and treated with laser photocoagulation, and 1 (%1.8) of these cases developed permanent visual loss. Conclusion: Development of ROP which is the second cause of acquired visual loss in the world has multifactorial etiology and for reducing the incidence low birth weight babies should be examined with taking into account these factors

Özet

Amaç: Çalışmamızda hastanemiz yenidoğan yoğun bakım ünitesinde yatan çok düşük doğum ağırlıklı bebeklerde prematüre retinopatisi (ROP) gelişim sıklığının belirlenmesi ve ROP gelişimi ile ilişkili etmenlerin araştırılması amaçlandı. Gereç ve Yöntem: Hastanemizde 1 Ocak 2007- 31 Aralık 2011 tarihleri arasında izlenen ve doğum ağırlığı 1500 gram altında olan 246 bebek retrospektif olarak değerlendirildi. Prematüre retinopatisi gelişiminde etkili olan faktörler incelendi. Bulgular: Bu hastaların 55’inde (%22.4) ROP tanısı konuldu. Ortalama gebelik süresi; ROP tanısı alan bebeklerde 28.0±2.3 hafta olup gebelik haftası azaldıkça ROP gelişme riskinin anlamlı olarak arttığı görüldü (p: 0.011). Prematüre retinopatisi saptanan 55 bebeğin, 29’u (%52.7) Evre 1, 17’si (%30.9) Evre 2, 8’i (%14.6) Evre 3 ve 1’i (%1.8) Evre 5 ROP olarak izlendi. ROP gelişimi ile PDA, ileri evre NEK (evre 2-3), sepsis, BPD varlığı ve transfüze olma sıklığı arasında istatistiksel olarak anlamlı birliktelik saptandı (p değerleri sırasıyla; p=0.0001, p=0.004, p=0.003, p=0.0001 ve p=0.002). Mekanik ventilasyon, CPAP uygulaması, surfaktan uygulaması arasında ilişki saptanmadı. Annede hipertansiyon, diabet, preeklampsi, annenin sigara kullanımı, yaş ortalaması ve doğum şekli gibi faktörlerin ROP ile ilişkisi saptanmadı. Prematüre retinopatisi saptanan 55 olgunun 9’unda (%16.4) Evre≥3 ROP saptanarak lazer fotokoagülasyon tedavisi uygulandı ve bu olguların birinde (%1.8) kalıcı görme kaybı gelişti. Sonuç: Dünyada edinsel görme kaybının ikinci en sık nedeni olan ROP’un multifaktöriyel etmenlerle geliştiği ve sıklığı azaltmak için düşük doğum tartılı bebeklerin bu etkenler göz önüne alınarak irdelenmesi gerektiğini düşünüyoruz

🔖

Cite This Article

BABAYİT, A., BÜLBÜL, A., TÜRKOĞLU, E. Ü., USLU, S., GÜRAN, Ö., ZUBARİOĞLU, U., DURSUN, M. (2014). Evaluation of incidence and effective risk factors in development of retinopathy of prematurity. Bakırköy Tıp Dergisi, Cilt: 10 - Sayı: 4, 158–164. https://ajindex.com/articles/129005

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Şener EC. Göz Hastalıkları. Yurdakök M, Erdem G (Eds). Neonatoloji
  2. Baskı. Alp Ofset I. 2004; p. 856-84
  3. Hussain N, Clive J, Bhandari V. Current incidence of ROP: 1989-1997. Pediatrics 1999; 104: 26-34 3. Steinkuller PG, Du L, Gilbert C, Foster A, Collins ML, Coats DK. Childhood blindness. J AAPOS 1999; 3: 26-32
  4. Madan A, Good WV. Disorders of the eye. In: HW Taeusch, and RA Ballard (Eds). Avery’s diseases of the newborn, 8th edition, Philadelphia, Elsevier Saunders; 2005: p. 1539-1555
  5. Coats DK, Aaron MM, Mohamed AH. Involution of retinopathy of prematurity after laser treatment: Factors associated with development of retinal detachment. Am J Ophthalmol 2005; 140: 214-222
  6. Gilbert C, Foster A. Childhood blindness in the context of VISION 2020 the right to sight. Bull World Health Organ 2001; 79: 227-232
  7. Terry TL. Extreme prematurity and fibroblastic overgrowth of persistant vascular sheat behind each crystalline lens. Am J Ophtalmol 1942; 25: 203-204
  8. Owens WC, Owens EU. Rentrolental fibroplasia in premature infants: 2. Studies on the prophylaxis of the disease. The use of alpha tocopheryl acetate. Am J Ophtalmol 1949; 32: 1631-1637
  9. Arsan S. Prematüre Retinopatisi. Türkiye Klinikleri Pediatri 2004; 2: 382-386
  10. Hunter DJ, Mukai S, Hirose T. Advanced retinopathy of prematurity. In: Albert DM, Jacobiec FA (Eds). Principles and Practice of Ophthalmology. Philadelphia: WB Saunders; 1994: p. 782-791
  11. Fierson WM; American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013; 131: 189-195
  12. Mahieu LM, De Muynck AO, De Dooy JJ, et al. Prediction of nosocomial sepsis in neonates by means of a computer-weighted bedside scoring system (NOSEP score). Crit Care Med 2000; 28: 2026-2033
  13. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of the subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92: 529-534
  14. Walsh M, Kliegman RM. Necrotizing enterocolitis:treatment based on staging criteria. Pediatr Clin North Am 1986; 33: 179-201
  15. Jobe AH, Bancalari E. Bronchopulmonary dysplasia.Am J Respir Crit Care Med 2001; 163: 1723-1729
  16. Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopa